Capstone Therapeutics Corp (CAPS.PK)
CAPS.PK on OTC Markets Group
0.20USD
1 Aug 2013
0.20USD
1 Aug 2013
Price Change (% chg)
$-0.03 (-13.04%)
$-0.03 (-13.04%)
Prev Close
$0.23
$0.23
Open
$0.20
$0.20
Day's High
$0.20
$0.20
Day's Low
$0.20
$0.20
Volume
5,650
5,650
Avg. Vol
39,370
39,370
52-wk High
$0.26
$0.26
52-wk Low
$0.12
$0.12
About
Capstone Therapeutics Corp. (Capstone Therapeutics), formerly OrthoLogic Corp., is a biotechnology company engaged in developing a pipeline of therapeutic peptides aimed at helping patients with under-served medical conditions. AZX100 is a synthetic 24-amino acid peptide. Chrysalin (TP508), a synthetic 23-amino acid peptide,... (more)
No analyst recommendations are available for CAPS.PK.
Overall
| Beta: | 0.45 |
| Market Cap (Mil.): | $9.40 |
| Shares Outstanding (Mil.): | 40.89 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CAPS.PK | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -0.09 | -- | -- |
| ROI: | -35.91 | -2.58 | 18.76 |
| ROE: | -30.30 | -2.66 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Unigene Laboratories Inc (UGNEQ.PK) | $0.00 | +0.00 |
| Fibrocell Science Inc (FCSC.A) | $5.49 | +0.51 |
| RegeneRx Biopharmaceuticals, Inc. (RGRX.PK) | $0.07 | -0.01 |
| Emisphere Technologies, Inc. (EMIS.OB) | $0.23 | +0.01 |
| Palatin Technologies, Inc. (PTN.A) | $0.74 | +0.04 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: S&P Capital IQ Quantitative Report
|
$46.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: GlobalData
|
$125.00
|
|
Provider: GlobalData
|
$125.00
|
|
Provider: GlobalData
|
$125.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

